Employees: 03 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2018-10-16 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13008), Bouches-du-Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELEURL PHARMACIE LECAILLET : revenue, balance sheet and financial ratios
SELEURL PHARMACIE LECAILLET is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13008),
this company of category PME
shows in 2022 a revenue of 1.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELEURL PHARMACIE LECAILLET (SIREN 843134693)
Indicator
2023
2022
2021
2020
Revenue
N/C
1 921 376 €
N/C
N/C
Net income
98 520 €
144 826 €
208 010 €
173 293 €
EBITDA
N/C
174 419 €
N/C
N/C
Net margin
N/C
7.5%
N/C
N/C
Revenue and income statement
In 2023, SELEURL PHARMACIE LECAILLET generates positive net income of 99 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2023: 173 k€ -> 99 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
98 520 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 74%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
74.358%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
49.202%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
Debt ratio
296.007
153.552
98.256
74.358
Financial autonomy
21.222
34.804
43.07
49.202
Repayment capacity
None
None
4.305
None
Cash flow / Revenue
None%
None%
7.875%
None%
Sector positioning
Debt ratio
74.362023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.22
Average-12 pts over 3 years
In 2023, the debt ratio of SELEURL PHARMACIE LECAILLET (74.36) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
49.2%2023
2021
2022
2023
Q1: 28.71%
Med: 48.51%
Q3: 68.18%
Good+14 pts over 3 years
In 2023, the financial autonomy of SELEURL PHARMACIE LECAILLET (49.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
4.3 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELEURL PHARMACIE LECAILLET (4.30) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 265.89. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
Liquidity ratio
213.645
293.507
251.208
265.895
Interest coverage
None
None
2.062
None
Sector positioning
Liquidity ratio
265.892023
2021
2022
2023
Q1: 135.26
Med: 189.75
Q3: 270.27
Good
In 2023, the liquidity ratio of SELEURL PHARMACIE LECAILLET (265.89) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
2.06x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of SELEURL PHARMACIE LECAILLET (2.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELEURL PHARMACIE LECAILLET
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
Operating WCR
0 €
0 €
179 822 €
0 €
Inventory turnover (days)
0
0
29
0
Customer payment term (days)
0
0
2
0
Supplier payment term (days)
0
0
49
0
Positioning of SELEURL PHARMACIE LECAILLET in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELEURL PHARMACIE LECAILLET is estimated at
1 162 484 €
(range 706 962€ - 1 634 192€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
706k€1162k€1634k€
1 162 484 €Range: 706 962€ - 1 634 192€
NAF 5 année 2023
Valuation method used
Net Income Multiple
98 520 €
×
11.8x
=1 162 484 €
Range: 706 962€ - 1 634 192€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELEURL PHARMACIE LECAILLET with other companies in the same sector:
Frequently asked questions about SELEURL PHARMACIE LECAILLET
What is the revenue of SELEURL PHARMACIE LECAILLET ?
The revenue of SELEURL PHARMACIE LECAILLET in 2022 is 1.9 M€.
Is SELEURL PHARMACIE LECAILLET profitable?
Yes, SELEURL PHARMACIE LECAILLET generated a net profit of 99 k€ in 2023.
Where is the headquarters of SELEURL PHARMACIE LECAILLET ?
The headquarters of SELEURL PHARMACIE LECAILLET is located in MARSEILLE (13008), in the department Bouches-du-Rhone.
Where to find the tax return of SELEURL PHARMACIE LECAILLET ?
The tax return of SELEURL PHARMACIE LECAILLET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELEURL PHARMACIE LECAILLET operate?
SELEURL PHARMACIE LECAILLET operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart